BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12960935)

  • 1. Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
    Alyan O; Arda K; Ozdemir O; Acu B; Soylu M; Demirkan D
    Med Sci Monit; 2003 Sep; 9(9):PI117-22. PubMed ID: 12960935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Piga M; Cocco MC; Serra A; Boi F; Loy M; Mariotti S
    Eur J Endocrinol; 2008 Oct; 159(4):423-9. PubMed ID: 18603573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
    J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Radiopharmaceuticals in Amiodarone-Induced Thyroid Pathology.
    Irimie A; Piciu D
    Curr Radiopharm; 2017 Nov; 10(3):146-154. PubMed ID: 28814251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
    Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response.
    Wong R; Cheung W; Stockigt JR; Topliss DJ
    Intern Med J; 2003; 33(9-10):420-6. PubMed ID: 14511194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Trip MD; Wiersinga W; Plomp TA
    Am J Med; 1991 Nov; 91(5):507-11. PubMed ID: 1951413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of amiodarone on the thyroid.
    Martino E; Bartalena L; Bogazzi F; Braverman LE
    Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.